ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2026
A rapid surveillance of pneumonia in hospitalized patients: an opportunity for intervention.
Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most evaluations of the burden of pneumonia in hospitalized patients are partial and concern specific subgroups of patients. However, few studies allow for the assessment of the global scope of the problem and the potential for intervention with guidance that could improve its diagnosis and treatment. This descriptive study conducted in a tertiary-care center aimed to determine the prevalence of pneumonia in hospitalized adults, to characterize its origins and etiology, and to evaluate the feasibility of a telematic intervention to advise on its diagnosis and treatment. A prevalence study was performed on the 653 adult inpatients admitted in July 2025. The pneumonia prevalence per 1,000 admitted patients was overall 36.8, community-acquired 24.5, nosocomial non-ventilator-associated 9.2, and nosocomial ventilator-associated 3.1. An etiological agent was identified in 29.2% of cases. In a critical review of the cases, opportunities to optimize either diagnosis or treatment were detected in 100% of pneumonia patients. After 30 days of dynamic follow-up of the selected cohort, overall mortality was 16.7%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.